Transjugular intrahepatic portosystemic shunt for treatment of portal hypertension due to extramedullary hematopoiesis in idiopathic myelofibrosis-Reference-Cited by-同舟云学术

Transjugular intrahepatic portosystemic shunt for treatment of portal hypertension due to extramedullary hematopoiesis in idiopathic myelofibrosis

Published:2002-06-01 Issue:11 Volume:99 Page:4246-4247
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Angermayr Bernhard¹,Cejna Manfred¹,Schoder Maria¹,Wrba Fritz¹,Valent Peter¹,Gangl Alfred¹,Peck-Radosavljevic Markus¹

Affiliation:

1. Correspondence: Markus Peck-Radosavljevic, Department of Gastroenterology and Hepatology, University of Vienna Medical School, Waehringer Guertel 18-20, A-1090 Vienna, Austria; e-mail:

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/99/11/4246/1685271/h81102004243c.pdf

Reference10 articles.

1. Agnogenic myeloid metaplasia (AMM): correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients.;Thiele;Hematol Oncol.,1989

2. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients.;Visani;Br J Haematol.,1990

3. Portal hypertension in the myeloproliferative syndrome and the reticuloses.;Shaldon;Am J Med.,1962

4. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art.;Rossle;Liver.,1998

5. The use and misuse of transjugular intrahepatic portasystemic shunts.;Sanyal;Curr Gastroenterol Rep.,2000

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Primary myelofibrosis presenting with portal hypertension mimicking cirrhosis;Frontiers in Medicine;2024-05-03

2. Splenic artery embolization for treatment of portal hypertension due to essential thrombocythemia;Portal Hypertension & Cirrhosis;2022-09

3. Spleen Stiffness by Ultrasound Elastography;Diagnostic Methods for Cirrhosis and Portal Hypertension;2018

4. Disease burden for the patient with myelofibrosis: goals and response with therapy;Novel Insights into Myelofibrosis Pathophysiology and Treatment;2015-05

5. Portale Hypertension;Wiener klinische Wochenschrift Education;2013-06-28